TBO Tek
- Market Cap
- ₹16,803 Cr
- P/E
- 61.53
Key Fundamentals
SmallcapLeisure ServicesConsumer ServicesPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 18.30%
- Debt to Equity
- 0.39
- EPS (TTM)
- ₹25.15
- Book Value
- ₹159.96
- Market Cap
- ₹16,803 Cr
- P/E (TTM)
- 61.53
- P/B
- 9.67
- ROE
- 17.50%
- Dividend Yield
- 0.00%
- EBITDA
- ₹421 Cr
- 52W High
- ₹1,772.50
- 52W Low
- ₹1,004.20
- Day Range
- ₹1,531.70 – ₹1,576.50
- Volume
- 1,12,310
Peer Comparison
Consumer Discretionary › Leisure Services › Tour, Travel Related Services
| 448.05 | 27.29 | 35,844 | 7.37 | 2.03% | 34.70% | 46.10% | 5,612 | 1,314 | |
| 1,547.40 | 61.53 | 16,803 | 9.67 | 0.00% | 17.50% | 18.30% | 3,390 | 273 | |
| 222.78 | 12.80 | 9,173 | 3.25 | 1.10% | 32.20% | 29.80% | 3,414 | 761 | |
| 170.20 | 49.91 | 7,507 | 3.46 | 0.00% | 5.03% | 6.14% | 1,305 | 153 | |
| 85.81 | — | 6,212 | 8.55 | 0.00% | 92.30% | 64.00% | 696 | 108 | |
| 114.66 | 26.42 | 5,393 | 2.03 | 0.45% | 9.21% | 14.90% | 7,952 | 194 | |
| 6.17 | — | 2,459 | 2.36 | 1.56% | −0.46% | 0.61% | 596 | −24 | |
| Median 7 companies | 170.20 | 27.29 | 7,507 | 3.46 | 0.45% | 17.50% | 18.30% | 3,390 | 194 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 47
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 15
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 99
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 41
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 70
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is expected to give good quarter
- Company has delivered good profit growth of 90.5% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 24.6%
Weaknesses
3- Stock is trading at 9.67 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 724 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 7 | 4 |
| Oscillators | Bullish | 0 | 7 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 43.31
- Neutral
- MACD (12,26,9)
- −11.44
- Bullish
- SMA (50)
- 1,621.81
- Bearish
- SMA (200)
- 1,436.71
- Bullish
As of
Analyst Rating
13 of 13 analysts rate Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 5Y | +79.92% |
|---|---|
| 3Y | +35.97% |
| 1Y | +54.12% |
| TTM | +74.11% |
Net profit
| 5Y | Turned to profit |
|---|---|
| 3Y | +18.13% |
| 1Y | +6.09% |
| TTM | +13.75% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +28.91 pp |
|---|---|
| 3Y | −3.63 pp |
| 1Y | −2.29 pp |
| TTM | −0.35 pp |
Revenue by year
| Mar 2018 | ₹343 Cr |
|---|---|
| Mar 2019 | ₹441 Cr |
| Mar 2020 | ₹571 Cr |
| Mar 2021 | ₹142 Cr |
| Mar 2022 | ₹483 Cr |
| Mar 2023 | ₹1,065 Cr |
| Mar 2024 | ₹1,393 Cr |
| Mar 2025 | ₹1,737 Cr |
| Mar 2026 | ₹2,677 Cr |
Net profit by year
| Mar 2018 | ₹36.00 Cr |
|---|---|
| Mar 2019 | ₹26.00 Cr |
| Mar 2020 | ₹73.00 Cr |
| Mar 2021 | −₹34.00 Cr |
| Mar 2022 | ₹34.00 Cr |
| Mar 2023 | ₹148 Cr |
| Mar 2024 | ₹201 Cr |
| Mar 2025 | ₹230 Cr |
| Mar 2026 | ₹244 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
TBO Tek Ltd trades at ₹1,565.7 as of 2026-11-19 with a market cap of ₹17,002 Cr, commanding a PE of 62.25x and a PB of 9.79x. The company has delivered strong 5-year profit CAGR of 90% and 5-year sales CAGR of 80%, but pays no dividend and carries elevated debtor days of 724, raising questions about cash conversion despite reported profitability.
- Exceptional 5-year compounded profit growth of 90% CAGR demonstrates a strong earnings trajectory and scalable business model
- 5-year compounded sales growth of 80% CAGR indicates rapid top-line expansion in the travel technology platform space
- TTM sales growth of 74% shows the revenue momentum is sustaining even on a larger base
- TTM profit growth of 28% confirms continued bottom-line expansion in the most recent period
- 3-year average ROE of 25% reflects consistently efficient capital allocation and strong returns for shareholders
- Current price of ₹1,565.7 is approximately 56% above the 52-week low of ₹1,004.2, indicating significant recovery and investor confidence
- Debt-to-equity ratio of 0.49 is relatively conservative, suggesting the balance sheet is not overleveraged despite rapid growth
- Company is expected to deliver a good upcoming quarter, which could further support the earnings growth narrative
- Debtor days of 724 are extremely elevated, raising serious concerns about working capital efficiency and the quality of reported revenue and profits
- PE of 62.25x is a rich valuation that leaves little room for execution missteps and prices in significant future growth
- Price-to-book of 9.79x is very high, meaning investors are paying a steep premium over the company's net asset value
- Zero dividend yield despite repeated profitability means shareholders receive no direct cash returns from their investment
- Stock has delivered a negative 1-year CAGR of -7%, underperforming despite strong underlying profit growth, suggesting possible valuation compression
- Current price of ₹1,565.7 sits roughly 12% below the 52-week high of ₹1,772.5, indicating the stock has lost momentum from its peak
- Last year ROE declined to 18% from the 3-year average of 25%, suggesting potential margin pressure or capital efficiency dilution
- ROCE of 14.99% lags meaningfully behind the 3-year ROE average of 25%, indicating that returns on total capital employed are more modest than equity returns alone suggest
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: TBO Tek is delivering strong top-line momentum with Q2 revenue up 52.5% and healthy EBITDA expansion, though net profit growth of 12.4% lags revenue growth, suggesting rising costs or investments. No material headwinds surfaced in the period. The institutional investor engagement and robust bookings suggest continued growth visibility, but sustaining 50%+ revenue growth will be the key metric to watch in coming quarters.
- Q2 profit up, revenue surges Nov 02
Q2 FY27 net profit rose 12.4% YoY to ₹76 crore while revenue jumped 52.5% to ₹866 crore, driven by strong booking volumes. EBITDA grew 54.1% to ₹136 crore with margin improving to 15.7% from 15.5%.
- Stock rallies on strong results Nov 02
Shares closed 4.22% higher at ₹1,596.80 on the NSE, reflecting investor confidence in the company's growth trajectory and operational improvements.
- UBS investor conference call scheduled Nov 19
TBO Tek scheduled a virtual institutional investor conference call on November 24, 2026. No unpublished price-sensitive information will be disclosed.
- RTA KFin relocates office Nov 04
Registrar and Share Transfer Agent KFin Technologies will relocate its Hyderabad corporate office effective December 1, 2026. No impact on shareholder services expected.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 352 | 327 | 369 | 418 | 451 | 422 | 446 | 511 | 568 | 784 | 814 | 926 | 866 |
| Expenses | 283 | 271 | 304 | 340 | 375 | 367 | 381 | 437 | 479 | 684 | 709 | 788 | 730 |
| Operating Profit | 70 | 56 | 66 | 79 | 75 | 55 | 65 | 74 | 88 | 100 | 105 | 138 | 136 |
| OPM % | 20% | 17% | 18% | 19% | 17% | 13% | 15% | 14% | 16% | 13% | 13% | 15% | 16% |
| Other Income | 1 | 12 | 7 | 15 | 15 | 16.57 | 16.41 | 20 | 15 | 7 | 13 | 13 | 14.76 |
| Interest | 2 | 3 | 4 | 6 | 6 | 6 | 5 | 5 | 9 | 15 | 15 | 15 | 16.96 |
| Depreciation | 7 | 8 | 15 | 12 | 13 | 13 | 14 | 14 | 16 | 26 | 30 | 33 | 33.84 |
| Exceptional Items | — | — | — | — | — | 3.72 | 8.99 | — | — | — | — | — | −8.14 |
| PBT | 62 | 57 | 53 | 76 | 71 | 57 | 71 | 75 | 78 | 66 | 74 | 103 | 91.54 |
| Tax % | 10% | 11% | 13% | 19% | 16% | 12% | 17% | 16% | 14% | 19% | 18% | 19% | 17% |
| Net Profit | 56 | 51 | 46 | 61 | 60 | 50 | 59 | 63 | 68 | 54 | 60 | 83 | 75.99 |
| EPS (₹) | 5.41 | 4.93 | 4.47 | 5.61 | 5.53 | 4.60 | 5.43 | 5.80 | 6.22 | 4.94 | 5.53 | 7.68 | 7.00 |
| YoY Sales growth | — | — | 31 | 21 | 28 | 29 | 21 | 22 | 26 | 86 | 83 | 81 | 53 |
Profit & Loss
₹ Cr| Particulars | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 220 | 343 | 441 | 571 | 142 | 483 | 1,065 | 1,393 | 1,737 | 2,677 | 3,390 |
| Expenses | 195 | 292 | 395 | 484 | 163 | 451 | 876 | 1,132 | 1,453 | 2,299 | 2,911 |
| Operating Profit | 25 | 51 | 46 | 87 | −21 | 32 | 189 | 261 | 285 | 378 | 479 |
| OPM % | 11% | 15% | 10% | 15% | −15% | 7% | 18% | 19% | 16% | 14% | 14% |
| Other Income | 12 | 9 | −1 | 18 | 5 | 37 | 24 | 22.66 | 61.83 | 51.23 | 39 |
| Interest | 0 | 5 | 6 | 5 | 2 | 7 | 14 | 19 | 33 | 52 | 61 |
| Depreciation | 1 | 1 | 5 | 12 | 11 | 16 | 25 | 36 | 52 | 86 | 123 |
| Exceptional Items | — | — | — | — | — | — | — | — | 12.71 | — | — |
| PBT | 36 | 53 | 34 | 88 | −30 | 46 | 174 | 227 | 275 | 293 | 335 |
| Tax % | 35% | 33% | 23% | 17% | 16% | 27% | 15% | 12% | 16% | 17% | — |
| Net Profit | 24 | 36 | 26 | 73 | −34 | 34 | 148 | 201 | 230 | 244 | 273 |
| EPS (₹) | 2.26 | 3.41 | 2.53 | 7.00 | −3.28 | 3.23 | 13.84 | 19.39 | 21.17 | 22.50 | 25.15 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Sales growth | — | — | 29 | 29 | −75 | 241 | 120 | 31 | 25 | 54 | 74 |
Balance Sheet
₹ Cr| Particulars | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 10 | 10 | 10 | 11 | 11 | 11 |
| Reserves | 85 | 130 | 159 | 238 | 202 | 221 | 330 | 534 | 1,184 | 1,540 | 1,726 |
| Borrowings | 0 | 0 | 21 | 17 | 8 | 63 | 71 | 210 | 214 | 756 | 671 |
| Other Liabilities | 249 | 462 | 644 | 536 | 364 | 976 | 2,147 | 4,100 | 4,797 | 6,996 | 7,524 |
| Total Liabilities | 336 | 594 | 826 | 793 | 576 | 1,271 | 2,558 | 4,855 | 6,206 | 9,303 | 9,932 |
| Fixed Assets | 1 | 2 | 44 | 35 | 23 | 92 | 136 | 349 | 345 | 1,619 | 1,628 |
| CWIP | 0 | 0 | 0 | 4 | 9 | 0 | 0 | 14 | 39 | 14 | 0 |
| Investments | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 173 | 263 | 273 |
| Other Assets | 319 | 592 | 782 | 755 | 545 | 1,179 | 2,422 | 4,490 | 5,649 | 7,407 | 8,031 |
| Total Assets | 336 | 594 | 826 | 793 | 576 | 1,271 | 2,558 | 4,855 | 6,206 | 9,303 | 9,932 |
Cash Flow
₹ Cr| Particulars | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 38 | 6 | 93 | −3 | 51 | 198 | 237 | 226 | 289 | −21 |
| Investing | 5 | 7 | −39 | −6 | −28 | −27 | −85 | −154 | −443 | −361 |
| Financing | 0 | −5 | −5 | −8 | −5 | −16 | −14 | 115 | 365 | 441 |
| Net Cash Flow | 43 | 8 | 49 | −18 | 17 | 156 | 138 | 188 | 210 | 60 |
| Free Cash Flow | 38 | 5 | 75 | −12 | 43 | 184 | 230 | 188 | 236 | −87 |
| CFO/EBITDA | 166 | 34 | 231 | 11 | −255 | 674 | 138 | 97 | 112 | 9 |
Ratios
| Particulars | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 211 | 311 | 314 | 194 | 309 | 401 | 537 | 867 | 853 | 724 |
| Cash Conversion Cycle | 211 | 311 | 314 | 194 | 309 | 401 | 537 | 867 | 853 | 724 |
| Working Capital Days | −141 | −81 | −129 | −36 | −391 | −234 | −137 | −114 | −104 | −134 |
| ROCE % | — | — | 29% | 42% | 1% | 18% | 53% | 43% | 27% | 18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view TBO Tek insights
63 extracted metrics across FY18–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript Recording
- Q1 FY27 concall · Aug 2026Transcript Recording
- Concall · Jul 2026Recording
- Q4 FY26 concall · Jun 2026Transcript PPT
- Q4 FY26 concall · Jun 2026PPT
- 29 Jul 2026
- 15 Dec 2025
- 12 Sep 2025
- 2 Apr 2025
- 2 Apr 2024
- 1 Apr 2022
- General announcements 19 Nov 2026
- General announcements 12 Nov 2026
- General announcements 4 Nov 2026
Frequently Asked Questions about TBO Tek
What does TBO Tek Ltd do?
Where is TBO Tek Ltd (TBOTEK) listed?
Which sector does TBO Tek Ltd belong to?
What is the market capitalisation of TBO Tek Ltd?
What is the PE ratio of TBO Tek Ltd?
What is the 52-week high and low of TBO Tek Ltd?
What is the Return on Equity (ROE) of TBO Tek Ltd?
Company Information
Incorporated in 2006, TBO Tek Ltd is in the business of operating multiple online technology platforms and providing access to book global travel inventory aggregated through travel suppliers like airlines, hotels, etc.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TBOTEK.md for TBO Tek Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.